Hercules Capital

Hercules is the largest non-bank lender to venture capital-backed companies at all stages of development in a broadly diversified variety of technology, life sciences, and sustainable and renewable technology industries. With over a decade of experience in venture debt, Hercules is uniquely positioned to quickly create innovative financing solutions that perfectly fit within a company's existing capital structure and map to its business objectives. Recognized as the industry leader, Hercules understands the flexibility these types of companies need and has the experience to work closely with them, even through challenging times, to help them reach critical milestones. Hercules' deep sector expertise, geographic presence and its strong capital base have made Hercules the lender of choice for more than 480 innovative companies.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Hercules Capital achieves record performance in 2022, eyes growth opportunities

Hercules Capital's 2022 performance was exceptional, marked by record results and strong credit quality. The company's focus for 2023 includes maintaining a strong balance sheet, disciplined underwriting, and strategic investments. Anticipate increased VC investment activity and an uptick in M&A transactions in the coming year.

Hercules Capital excels in Q1 2023, eyes strategic partnerships

Hercules Capital's Q1 2023 showcased resilience and growth, with strong financial metrics and strategic initiatives. Despite market challenges, the company maintained credit quality and liquidity while exploring opportunities for expansion and partnership enhancement.

Hercules Capital (HTGC) reports record Q2 results and eyes market growth opportunities

Hercules Capital delivered strong Q2 results with record investment income and robust credit quality, showcasing expertise in deal selection and industry diversification.
While facing challenges in meeting earnings expectations and providing detailed diversification insights, the company's strong liquidity and market positioning offer opportunities for future growth and strategic investments.
Overall, Hercules Capital's performance highlights resilience in a dynamic market environment, emphasizing its potential for sustained growth and value creation for investors.

Hercules Capital (HTGC) reports record Q3 earnings and strategic growth

Hercules Capital (HTGC) delivered exceptional financial results in Q3 2023, marked by record earnings and prudent portfolio management.
The company's strategic focus on credit quality, portfolio diversification, and liquidity positions it well for future growth and investment opportunities.
Despite challenges such as asset valuation fluctuations, Hercules Capital remains resilient and poised to capitalize on market dynamics for sustained success.

Hercules Capital reports record Q4 performance and eyes growth opportunities

Hercules Capital (HTGC) delivered strong financial performance in Q4 2023, emphasizing quality, diversification, and growth in key sectors like life sciences.
While challenges exist in managing expenses and optimizing capital efficiency, the company's conservative approach and liquidity position provide a solid foundation for future success.
Opportunities lie in expanding the venture and growth stage asset class, driving platform growth, and engaging with investors at upcoming conferences.

Hercules Capital excels in Q1 2024, poised for strategic growth

Hercules Capital delivered exceptional performance in Q1 2024, with record origination and funding, strong investment income, improved credit quality, and robust liquidity, positioning the company for continued success.
The company's strengths lie in its solid balance sheet, under-levered position, focus on quality growth, and favorable standing with rating agencies, providing a strong foundation for future growth.
Challenges include managing leverage increase, debt refinancing, maintaining credit quality standards, and navigating market uncertainties, requiring strategic planning and risk management.
Opportunities for Hercules include leveraging its milestone anniversary, expanding investor base through conferences, exploring new investments, and driving sustainable growth through prudent strategies.

Hercules Capital posts record Q2 results amidst market volatility

Hercules Capital delivered a strong performance in Q2 2024, marked by record fundings and asset growth, despite anticipating increased market volatility ahead.
The company's focus on credit quality, liquidity, and diversification through SBIC licenses strengthens their resilience and growth prospects.
While facing challenges such as market volatility and prepayment expectations, Hercules Capital remains well-positioned to leverage opportunities and navigate uncertainties.

Hercules Capital (HTGC) reports record Q3 earnings amidst market challenges

Hercules Capital (HTGC) reported strong financial performance in Q3 with record total investment income and NII, despite challenges in the venture capital ecosystem.
Maintaining a defensive balance sheet approach and strong liquidity, Hercules is well-positioned to navigate market uncertainties and capitalize on growth opportunities.
While facing challenges from market slowdowns, Hercules' prudent underwriting and commitment to shareholder returns showcase resilience and long-term stability.
With opportunities arising from increased funding activity post-Fed rate action and pending commitments, Hercules is poised for potential growth in Q4 and beyond.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hercules Capital, Inc. is a specialty finance company, which focuses on providing senior secured loans to high-growth, innovative venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. The company was founded by Manuel A. Henriquez in December 2003 and is headquartered in Palo Alto, CA.

Hercules Capital is a fast-growing BDC with a unique focus on growth companies. Hercules' stock has a history of trading substantially above book value.

Hercules Capital: A Best-Of-Breed Tech BDC With A 7.4% Yield

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced two internal promotions and one new addition to the executive management team. Christian Follmann, currently Sr. Director of Operations and Strategic Projects, has been name

Hercules Capital Enhances C-Suite for Future Growth

Ares Capital

FS KKR Capital Corp

Gladstone Investment

Gladstone Investment Corp 6 1/4% Cum Term Pfd Shs Series D

Golub Capital BDC

PennantPark Investment

TCP Capital

We take a look at the action in BDCs through the second week of January and highlight some of the key themes we are watching. The BDC sector has remained resilient so far in 2022 despite lower stocks and Treasuries. In our view, this is due to a faster expected move through the NII valley.

BDC Sector Market Review: Debt Interest Costs Move Higher

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has closed an underwritten public offering of $350.0 million in aggregate principal amount of 3.375% notes due January 2027 (the “Notes”). The Notes are unsecured and bear interest at a rate of 3.375% per year, payable semiannually and will mature on January 20, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option at par,

Hercules Capital Closes Upsized Public Offering of $350.0 Million 3.375% Notes Due 2027

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), today announced that it has priced an underwritten public offering of $350.0 million in aggregate principal amount of 3.375% notes due January 2027 (the “Notes”). The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered and paid for on January 20, 2022. The Notes are unsecured and bear interest at a rate of 3.375% per year, payable se

Hercules Capital Prices Upsized Public Offering of $350.0 Million 3.375% Notes due 2027

Driven by the growing demand for customized financing, Hercules Capital's (HTGC) top line is expected to keep improving. Yet, elevated costs might hurt profitability.

Loan Originations Aid Hercules Capital (HTGC) Amid High Costs

Hercules Capital is strong financially and growing its investment income incrementally. The company currently pays an 8% dividend yield that is well covered.

Hercules Capital: Flexing The Financial Muscles

Hercules Capital has a strong track record of shareholder returns. It's currently operating in a very strong lending environment in the tech and life sciences segments.

Hercules Capital: I'm Reaching For This 8% Yielder On The Dip

AMSTERDAM--(BUSINESS WIRE)--NorthSea Therapeutics B.V. closes USD 80 million Series C financing to advance clinical programs, co-led by Ysios Capital and Forbion Growth.

NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic Disorders

Donegal Group

Dow Inc

International Paper

LyondellBasell Industries

Owl Rock Capital Corp

Old Republic International

Qiwi

Rio Tinto plc Sponsored

Sibanye Stillwater

Ternium

Unum

Xerox

"Benjamin Graham Value Stocks match the criteria Benjamin Graham followed. " - YCharts Value Screener. 35 Graham formula picks screened by YCharts December 10, 2021 are based on Graham's established value detection criteria. Of those, 24 matched the dogcatcher ideal showing dividends from $1k invested.

24 Dependable December Dividend Buys Revealed By Graham Formula

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it, together with external funds managed by its adviser subsidiary, have originated more than a record $2.0 billion year-to-date in annual total gross debt and equity c

Hercules Capital Surpasses $2.0 Billion in Annual Gross Debt and Equity Commitments for First Time in History

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that effective November 9, 2021, it has entered into a new $100.0 million multi-currency credit facility with Sumitomo Mitsui Banking Corporation (“SMBC”). SMBC has committe

Hercules Capital Further Strengthens Its Capital Resources With New $100.0 Million Multi-Currency Credit Facility

Fidus Investment

Horizon Technology Finance

We take a look at the action in BDCs through the last week of October and highlight some of the key themes we are watching. The BDC sector had a terrific October with a 5% rally overall - the best month since April this year.

BDC Market Weekly Review: Key Themes So Far Of This Earnings Season

Solid new debt and equity commitments along with robust liquidity position support Hercules Capital's (HTGC) Q3 results.

Hercules Capital (HTGC) Q3 Earnings Beat Estimates, Costs Up

Hercules Capital, Inc. (HTGC) CEO Scott Bluestein on Q3 2021 Results - Earnings Call Transcript

Hercules Tech (HTGC) delivered earnings and revenue surprises of 3.13% and -1.89%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Hercules Technology (HTGC) Tops Q3 Earnings Estimates

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the third quarter ended September 30, 2021. “Hercules' leadership position, scale and brand reputation as the largest nonbank provider of venture a

Hercules Capital Reports Third Quarter 2021 Financial Results

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a supplemental cash distribution of $0.07 per share. This supplemental cash distribution will be paid out of Hercules Capital

Hercules Capital Announces Supplemental Cash Distribution of $0.07 per Share for the Third Quarter of 2021

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has increased and declared a third quarter 2021 cash distribution of $0.33 per share. The following shows the key dates of the third quarte

Hercules Capital Increases Its Quarterly Cash Distribution to $0.33 per Share for the Third Quarter of 2021

Hercules Tech (HTGC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Hercules Technology (HTGC) Q3 Earnings Expected to Decline

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Pam Randhawa was appointed to serve as a member of its board of directors, effective November 1, 2021. Ms. Randhawa is a thought leader within the life sciences sector

Hercules Capital Announces the Appointment of Ms. Pam Randhawa to Its Board of Directors

Proceeds to be used to advance development of synthetic biology engine and manufacturing capabilities Proceeds to be used to advance development of synthetic biology engine and manufacturing capabilities

Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2021 financial results conference call for Thursday, October 28, 2021, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its fina

Hercules Capital Announces Date for Release of Third Quarter 2021 Financial Results and Conference Call

Hercules Capital is a tech and life sciences focused BDC, with a strong track record of shareholder returns. It carries a higher investment yield than most BDCs, and is seeing a very favorable demand environment.

Hercules Capital: Stash Cash With This Retirement Income Opportunity

BOSTON, Sept. 27, 2021 /PRNewswire/ -- Corium, Inc. (Corium), a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, today announces that it has closed on a $235 million term loan agreement with Hercules Capital, Inc. (NYSE: HTGC), a leader in specialty financing for life science and technology companies.

News for Hercules Capital ETF (HTGC)